As of today (2022-08-12), Neuronetics's share price is $4.46. Neuronetics's Tangible Book per Share of Jun. 2022 for the quarter that ended in Jun. 2022 was $2.55. Hence, Neuronetics's Price to Tangible Book Ratio of today is 1.75.
The historical rank and industry rank for Neuronetics's Price-to-Tangible-Book or its related term are showing as below:
STIM'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.97 Med: 2.98 Max: 8.33
Current: 1.75
During the past 6 years, Neuronetics's highest Price to Tangible Book Ratio was 8.33. The lowest was 0.97. And the median was 2.98.
STIM's Price-to-Tangible-Book is ranked better than 73.4% of 188
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.35
vs STIM: 1.75
A closely related ratio is called PB Ratio. As of today, Neuronetics's share price is $4.46. Neuronetics's Book Value per Sharefor the quarter that ended in Jun. 2022 was $2.55. Hence, Neuronetics's P/B Ratio of today is 1.75.
Neuronetics Price-to-Tangible-Book Historical Data
The historical data trend for Neuronetics's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Neuronetics Annual Data
Trend
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Price-to-Tangible-Book
-
4.83
1.75
8.33
1.38
Neuronetics Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Price-to-Tangible-Book
4.31
1.90
1.38
1.06
1.26
Competitive Comparison
For the Diagnostics & Research subindustry, Neuronetics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neuronetics Price-to-Tangible-Book Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, Neuronetics's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Neuronetics's Price-to-Tangible-Book falls into.
Neuronetics Price-to-Tangible-Book Calculation
Neuronetics's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Neuronetics Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Neuronetics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.01(0.22%) Volume: 120,343 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:STIM has been successfully added to your 
